Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
AQST
AQST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest AQST ETF News Today | Earnings, Events & Price Alerts
AQST News
Aquestive Therapeutics to Announce Q4 Earnings on March 4
19h ago
seekingalpha
Faruqi & Faruqi Investigates Losses in Aquestive Therapeutics
4d ago
PRnewswire
Aquestive Therapeutics to Present at Oppenheimer Conference
Feb 23 2026
Yahoo Finance
Anaphylm™ Sublingual Film Clinical Data Released
Feb 20 2026
Newsfilter
Aquestive Therapeutics Appoints New Chief Medical Officer
Feb 18 2026
NASDAQ.COM
Faruqi & Faruqi Investigates Aquestive Therapeutics After 40% Stock Plunge
Feb 15 2026
Globenewswire
Faruqi & Faruqi Investigates Investor Losses in Aquestive Therapeutics
Feb 13 2026
PRnewswire
Pomerantz LLP Investigates Securities Fraud Claims Against Aquestive Therapeutics
Feb 13 2026
PRnewswire
Faruqi & Faruqi Investigates Aquestive Therapeutics After FDA Concerns
Feb 07 2026
PRnewswire
Faruqi & Faruqi Investigates Aquestive Therapeutics' FDA Issues
Feb 04 2026
Globenewswire
Pomerantz LLP Investigates Fraud Claims Against Aquestive Therapeutics
Feb 03 2026
Globenewswire
Aquestive Therapeutics Shares Surge 39% Despite FDA Complete Response Letter
Feb 02 2026
seekingalpha
Aquestive Therapeutics Receives Complete Response Letter from FDA
Feb 02 2026
Benzinga
Schall Law Firm Investigates Aquestive for Securities Violations
Feb 02 2026
Businesswire
Aquestive Therapeutics Stock Soars 43% Following FDA Complete Response Letter
Feb 02 2026
NASDAQ.COM
Aquestive Therapeutics Receives FDA Response Progress
Feb 02 2026
stocktwits
Show More News
